Belgium· BE-AMP-SAM444306-00
Nicorette Invisipatch 25 mg
A nicotine product containing nicotine, registered in Belgium by Kenvue Belgium. The same ATC class is registered in 15 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Nicotine is registered in 15 of 19 countries.
Countries holding a registration under ATC N07BA01 (nicotine), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Nicotine · ATC N07BA01
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of nicotine costs, country by country.
Normalised to the WHO defined daily dose (60 mg), the median price runs from $4.40 in France to $6.98 in United States — a ×1.6 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Nicotine · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- US United States$6.98 (acquisition cost)
- FR France$4.40
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Nicotine
- Manufacturer
- Kenvue Belgium
- Country
- Belgium (BE)
- ATC code
- N07BA01
- ATC class
- Nicotine
- Defined daily dose
- 60 mg, Inhalation
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb4175923
- be_apb3091618
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
129 interactions on record for nicotine.
Graded by severity as the source publishes them — 6 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nicotine · interactions on record
129 records
- 6 moderate
- 5 minor
- 118 info
Most severe, free to view
- CeritinibL01ED02moderate
- AlpelisibL01EM03moderate
- CeritinibL01XE28moderate
- AlpelisibL01XX65moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/50c5b959-9947-446f-ab08-bfa8cf1c78e6 GET /v1/drugs/50c5b959-9947-446f-ab08-bfa8cf1c78e6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Transdermal patch",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Nicorette Invisipatch 25 mg",
"name_fr": "Nicorette Invisipatch 25 mg",
"name_nl": "Nicorette Invisipatch 25 mg",
"amp_code": "SAM444306-00",
"strengths": [
"39.3700",
"39.3700",
"39.3700",
"1.8000"
],
"pack_count": 3,
"substances": [
"Nicotine",
"Potassium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Nicotine",
"authorisation_numbers": [
"BE444306"
]
}See everything about nicotine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.